UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1338) 1338
science & technology (1236) 1236
life sciences & biomedicine (1222) 1222
male (914) 914
ezetimibe (756) 756
azetidines - administration & dosage (741) 741
female (697) 697
azetidines - therapeutic use (682) 682
middle aged (516) 516
animals (487) 487
biological and medical sciences (469) 469
azetidines - pharmacology (467) 467
medical sciences (453) 453
pharmacology & pharmacy (419) 419
drug therapy, combination (392) 392
aged (390) 390
adult (359) 359
anticholesteremic agents - administration & dosage (345) 345
anticholesteremic agents - therapeutic use (333) 333
treatment outcome (327) 327
azetidines - adverse effects (309) 309
cardiovascular system & cardiology (307) 307
hypercholesterolemia - drug therapy (277) 277
cholesterol, ldl - blood (267) 267
pharmacology. drug treatments (253) 253
administration, oral (236) 236
cholesterol (230) 230
cardiac & cardiovascular systems (229) 229
azetidines - pharmacokinetics (222) 222
abridged index medicus (220) 220
dose-response relationship, drug (214) 214
benzylamines (212) 212
rats (195) 195
simvastatin - administration & dosage (193) 193
double-blind method (191) 191
drug therapy (169) 169
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (165) 165
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (160) 160
general & internal medicine (159) 159
medicine, general & internal (158) 158
statins (156) 156
anticoagulants - therapeutic use (150) 150
mice (149) 149
simvastatin - therapeutic use (141) 141
anticholesteremic agents - adverse effects (137) 137
peripheral vascular disease (137) 137
hypercholesterolemia (134) 134
anticholesteremic agents - pharmacology (132) 132
risk factors (129) 129
cardiology. vascular system (125) 125
simvastatin (125) 125
thrombin - antagonists & inhibitors (123) 123
randomized controlled trials as topic (121) 121
anticoagulants - administration & dosage (119) 119
lipids (119) 119
cardiovascular (118) 118
drug combinations (117) 117
time factors (115) 115
research (113) 113
hypercholesterolemia - blood (110) 110
aged, 80 and over (108) 108
analysis (108) 108
ximelagatran (108) 108
care and treatment (107) 107
clinical trials as topic (105) 105
rats, sprague-dawley (105) 105
atorvastatin calcium (101) 101
adolescent (99) 99
low density lipoproteins (97) 97
cardiovascular disease (96) 96
cholesterol - blood (96) 96
clinical trials (95) 95
azetidines - chemistry (93) 93
antilipemic agents (91) 91
medicine & public health (89) 89
sulfonamides - administration & dosage (88) 88
dosage and administration (87) 87
triglycerides - blood (85) 85
young adult (85) 85
atherosclerosis (84) 84
pyrroles - administration & dosage (82) 82
drug administration schedule (81) 81
hematology (81) 81
sulfonamides - therapeutic use (80) 80
azetidines (79) 79
glycine - analogs & derivatives (79) 79
heptanoic acids - administration & dosage (79) 79
anticoagulants - adverse effects (77) 77
drug interactions (77) 77
pharmacology/toxicology (77) 77
anticoagulants (76) 76
cholesterol, hdl - blood (73) 73
cholesterol, ldl - drug effects (73) 73
coronary heart disease (73) 73
internal medicine (73) 73
anticoagulants - pharmacology (72) 72
cholesterol - metabolism (70) 70
medicine, research & experimental (70) 70
research & experimental medicine (70) 70
hyperlipidemias - drug therapy (69) 69
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1566) 1566
German (37) 37
Japanese (17) 17
French (13) 13
Spanish (11) 11
Hungarian (8) 8
Italian (6) 6
Russian (6) 6
Turkish (5) 5
Czech (4) 4
Danish (3) 3
Portuguese (2) 2
Chinese (1) 1
Dutch (1) 1
Finnish (1) 1
Korean (1) 1
Lithuanian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American journal of clinical dermatology, ISSN 1175-0561, 06/2016, Volume 17, Issue 3, pp. 191 - 200
Life Sciences & Biomedicine | Dermatology | Science & Technology | Humans | Protein Kinase Inhibitors - adverse effects | Thiazoles - adverse effects | Thalidomide - analogs & derivatives | Isonicotinic Acids - administration & dosage | Phosphodiesterase 4 Inhibitors - adverse effects | Pyrroles - administration & dosage | Adenosine - adverse effects | Adamantane - therapeutic use | Pyrroles - adverse effects | Adamantane - administration & dosage | Receptors, Lysosphingolipid - metabolism | Adamantane - analogs & derivatives | Isonicotinic Acids - adverse effects | Thalidomide - adverse effects | Biological Therapy | Isonicotinic Acids - therapeutic use | Piperidines - administration & dosage | Psoriasis - drug therapy | Adenosine A3 Receptor Antagonists - therapeutic use | Administration, Oral | Azetidines - adverse effects | Niacinamide - adverse effects | Niacinamide - therapeutic use | Phosphodiesterase 4 Inhibitors - therapeutic use | Adenosine A3 Receptor Antagonists - adverse effects | Thalidomide - administration & dosage | Adenosine - administration & dosage | Protein Kinase Inhibitors - administration & dosage | Azetidines - therapeutic use | Adenosine - analogs & derivatives | Thalidomide - therapeutic use | Sulfonamides - administration & dosage | Niacinamide - analogs & derivatives | Thiazoles - administration & dosage | Thiazoles - therapeutic use | rho-Associated Kinases - antagonists & inhibitors | Phosphodiesterase 4 Inhibitors - administration & dosage | Adenosine - therapeutic use | Arthritis, Psoriatic - drug therapy | Pyrroles - therapeutic use | Adamantane - adverse effects | Adenosine A3 Receptor Antagonists - administration & dosage | Pyrimidines - administration & dosage | Clinical Trials as Topic | Niacinamide - administration & dosage | Biological Factors - therapeutic use | Janus Kinases - antagonists & inhibitors | Azetidines - administration & dosage | Sulfonamides - therapeutic use | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Piperidines - adverse effects | Pyrimidines - adverse effects | Sulfonamides - adverse effects
Journal Article
Pharmacotherapy, ISSN 0277-0008, 05/2020, Volume 40, Issue 5, pp. 416 - 437
dialysis | renal | antivirals | cytochrome P450 | infectious disease | liver | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Pandemics | Alanine - adverse effects | Adrenal Cortex Hormones | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Thiazoles - administration & dosage | Hydroxychloroquine - adverse effects | Thiazoles - adverse effects | Alanine - analogs & derivatives | Alanine - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Ritonavir - adverse effects | Ribavirin - administration & dosage | Betacoronavirus | Antibodies, Monoclonal, Humanized - adverse effects | Ritonavir - administration & dosage | Immunomodulation | Azetidines - adverse effects | Chloroquine - adverse effects | Antiviral Agents - administration & dosage | Adenosine Monophosphate - adverse effects | Hydroxychloroquine - administration & dosage | Nelfinavir - adverse effects | Interferon-alpha - administration & dosage | Azetidines - administration & dosage | Ribavirin - adverse effects | Adenosine Monophosphate - administration & dosage | Adenosine Monophosphate - analogs & derivatives | Antiviral Agents - adverse effects | Coronavirus Infections - therapy | Immunization, Passive | Lopinavir - administration & dosage | Sulfonamides - adverse effects | Chloroquine - administration & dosage | Interferon-alpha - adverse effects | Nelfinavir - administration & dosage | Drug Combinations | Lopinavir - adverse effects | Sulfonamides - administration & dosage | Severe acute respiratory syndrome coronavirus 2 | COVID-19 | Antiviral agents | Therapeutic applications | Clinical trials | Coronaviruses | Drug therapy | Patients | Index Medicus | Reviews of Therapeutics | Review of Therapeutics
Journal Article
Journal Article
The oncologist (Dayton, Ohio), ISSN 1083-7159, 07/2017, Volume 22, Issue 7, pp. 823 - 833
BRAF | Mitogen‐activated protein kinase signaling system | Drug‐related side effects and adverse reactions | Protein kinase inhibitors | Melanoma | Mitogen-activated protein kinase signaling system | Drug-related side effects and adverse reactions | Life Sciences & Biomedicine | Oncology | Science & Technology | Oximes - adverse effects | Humans | Fever - therapy | Oximes - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Imidazoles - administration & dosage | Carbamates - administration & dosage | Protein Kinase Inhibitors - adverse effects | Fever - chemically induced | Pyridones - administration & dosage | Benzimidazoles - administration & dosage | Antineoplastic Agents - adverse effects | Benzimidazoles - adverse effects | Skin Diseases - chemically induced | Piperidines - administration & dosage | Imidazoles - adverse effects | Pyrimidinones - adverse effects | Azetidines - adverse effects | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Melanoma - pathology | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Vemurafenib | Azetidines - administration & dosage | Indoles - adverse effects | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Piperidines - adverse effects | Sulfonamides - adverse effects | Carbamates - adverse effects | Pyrimidinones - administration & dosage | Pyridones - adverse effects | Sulfonamides - administration & dosage | Index Medicus | Melanoma and Cutaneous Malignancies
Journal Article
Journal Article
Mayo Clinic proceedings, ISSN 0025-6196, 07/2020, Volume 95, Issue 7, pp. 1404 - 1419
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2014, Volume 371, Issue 20, pp. 1867 - 1876
Journal Article